| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 626673 | Null | 0.0339770934764508 | 0.49163426 |
| NSC 632831 | Null | 0.0339770934764508 | 0.39574653 |
| NSC 639503 | Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.0339770934764508 | 0.38436257 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.0339770934764508 | 0.35676415 |
| NSC 641297 | ANTINEOPLASTIC-641297 | 0.0339770934764508 | 0.083132706 |
| NSC 644644 | Null | 0.0339770934764508 | -0.054143633 |
| NSC 645159 | Null | 0.0339770934764508 | 0.48024266 |
| NSC 646610 | Null | 0.0339770934764508 | 0.19980616 |
| NSC 653624 | Null | 0.0339770934764508 | 0.42282724 |
| NSC 658142 | 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin | 0.0339770934764508 | 0.42171909 |